Another small open study in 32 patients with both mild-to-moderate AD (or amnestic MCI) and diabetes mellitus not on insulin randomised patients between the PPARγ agonist pioglitazone or no additional treatment. The gene discussed is INS; the disease is diabetes mellitus.